Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roivant Sciences NasdaqGS:ROIV |
19,23 B | -17,10% | 2/4 | -76,60% | -940,11% | 28,40% | UP |
|
GW Pharmaceuticals NasdaqGM:GWPH |
6,91 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Centessa Pharmaceuticals NasdaqGS:CNTA |
4,07 B | 0,00% | 0/0 | 0,00% | 0,00% | 36,25% | UP |
|
Abcam NasdaqGM:ABCM |
3,56 B | -48,52% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Kiniksa Pharmaceuticals International NasdaqGS:KNSA |
3,44 B | 25,28% | 3/4 | 76,45% | -78,80% | 25,72% | UP |
|
Genus LSE:GNS |
1,67 B | 1,49% | 4/6 | 13,87% | 12,05% | 30,52% | UP |
|
Immunocore Holdings NasdaqGS:IMCR |
1,52 B | 53,28% | 5/6 | 12,68% | 32,83% | 107,01% | DOWN |
|
Oxford Nanopore Technologies LSE:ONT |
1,13 B | -0,86% | 1/5 | 20,55% | -5,41% | 66,67% | DOWN |
|
Oxford Biomedica LSE:OXB |
0,72 B | 7,84% | 1/6 | 37,82% | -32,53% | 35,41% | UP |
|
Allergy Therapeutics AIM:AGY |
0,67 B | -37,67% | 0/6 | 0,00% | -993,44% | 18,18% | UP |
|
Exscientia NasdaqGS:EXAI |
0,63 B | 0,00% | 0/0 | 79,95% | 0,00% | 29,96% | DOWN |
|
COMPASS Pathways NasdaqGS:CMPS |
0,59 B | 0,00% | 1/4 | 0,00% | 0,00% | 274,28% | DOWN |
|
Urovant Sciences NasdaqGM:UROV |
0,52 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Orchard Therapeutics NasdaqGM:ORTX |
0,38 B | 0,00% | 4/5 | 81,10% | -9,00% | -100,00% | UP |
|
Autolus Therapeutics NasdaqGS:AUTL |
0,35 B | 2,97% | 2/5 | 1214,87% | 90,02% | 581,82% | DOWN |
|
NIOX Group Plc AIM:NIOX |
0,25 B | 23,70% | 3/6 | 48,39% | 14,51% | 38,98% | DOWN |
|
Bicycle Therapeutics NasdaqGS:BCYC |
0,31 B | -7,85% | 0/5 | 2,17% | 54,07% | 166,67% | DOWN |
|
Horizon Discovery Group AIM:HZD |
0,16 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Tiziana Life Sciences Ltd NasdaqCM:TLSA |
0,17 B | 0,00% | 1/4 | 0,00% | 0,00% | 498,48% | DOWN |
|
Scancell Holdings AIM:SCLP |
0,12 B | 0,00% | 2/5 | 0,00% | 0,00% | 181,82% | UP |
